Advertisement
U.S. markets closed

Achieve Life Sciences, Inc. (ACHV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.6000+0.0100 (+0.22%)
At close: 04:00PM EDT
4.5100 -0.09 (-1.96%)
After hours: 06:11PM EDT

Achieve Life Sciences, Inc.

1040 West Georgia Street
Suite 1030
Vancouver, BC V6E 4H1
Canada
604 210 2217
https://www.achievelifesciences.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees20

Key Executives

NameTitlePayExercisedYear Born
Dr. Richard A. B. StewartExecutive Chairman575kN/A1959
Mr. John A. Bencich M.B.A.CEO & Director733.12kN/A1977
Dr. Cindy Jacobs M.D., Ph.D.President, Chief Medical Officer & Director614.25kN/A1958
Mr. Jerry WanPrincipal Accounting OfficerN/AN/A1982
Dr. Anthony ClarkeChief Scientific Officer546kN/A1956
Ms. Jaime XinosExecutive Vice President of CommercialN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Corporate Governance

Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.